Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fib...
Q1 2026
May 8, 2026
FY 2025
Mar 13, 2026
Q4 2025
Q3 2025
Nov 7, 2025
Q2 2025
Aug 11, 2025